Welcome to PsychU!

Virtual Event – Considerations & Factors For Initiating & Switching Antipsychotic Medications In Schizophrenia

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Virtual Event – Considerations & Factors For Initiating & Switching Antipsychotic Medications In Schizophrenia

This is a Virtual Event for PsychU members in New Jersey and New York.

In this presentation, the objectives are to:

  • Discuss factors to consider when initiating and switching antipsychotic treatments in schizophrenia
  • Review pharmacological and pharmacokinetic considerations
  • Discuss antipsychotic treatment switching strategies in schizophrenia
  • Identify potential steps in implementing a change in treatment regimen

Featuring

Salvatore G.-Savatta

Salvatore G. Savatta, MD

Chair of Psychiatry, Trinitas Regional Medical Center, Elizabeth, NJ

More
Dr. Salvatore G. Savatta received his Bachelor of Arts degree in Economics from New York University, graduated from New York University School of Medicine in 2001 and completed his M.S. in Biostatistics Clinical Research Methods at Columbia University’s Mailman School of Public Health in 2005. Dr. Savatta has previously served as Director of Inpatient Psychiatry at New York Methodist Hospital, Medical Director of TMS Centers of America and both Deputy Chair and Interim Chair of Psychiatry at Trinitas Regional Medical Center. He presently serves as Chair of Psychiatry at Trinitas and has done so since May of 2020. Dr. Savatta completed his Psychiatry Residency at St. Vincent’s Catholic Medical Center and completed a Public Service Psychiatry Fellowship and a Forensic Psychiatry Fellowship at the University of Pittsburgh Medical Center – Western Psychiatric Institute and Clinic. Dr. Savatta is Board Certified in both Adult Psychiatry and Forensic Psychiatry. He has tailored his clinical practice to focus on “difficult to treat” depression, and often includes the implementation of Neuromodulation techniques such as TMS, Esketamine, and Electroconvulsive Therapy (ECT) when clinically appropriate.
Becky-Wong

Becky Wong, PharmD, MBA (OPDC)

Neuroscience Senior Clinical & Scientific Liaison

Brijesh-Patel

Brijesh Patel, PharmD

Clinical & Scientific Liaison

Speaker Salvatore G. Savatta, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speakers Becky Wong, PharmD, MBA and Brijesh Patel, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Related Resources